Iron doesn’t cause cancer the way a carcinogen like tobacco smoke does, but excess iron in the body is consistently linked to higher cancer risk. The connection is strongest for two specific scenarios: eating large amounts of heme iron (the type found in red meat) and having chronically elevated iron stores due to genetics or other factors. For most people with normal iron levels, routine dietary iron is not a meaningful cancer concern.
How Excess Iron Damages Cells
Iron is essential for carrying oxygen in your blood and powering dozens of enzymes, but it has a dangerous side hustle. When iron accumulates beyond what the body needs, it participates in a chemical reaction that generates hydroxyl radicals, the most reactive molecules in biological systems. These radicals rip electrons from DNA, proteins, and cell membranes, causing the kind of damage that can eventually trigger cancerous mutations.
The process works like this: iron in its active form donates electrons to hydrogen peroxide (a normal byproduct of metabolism), splitting it into hydroxyl radicals. Only a small fraction of iron actually generates these radicals at any given moment, but over years of chronic excess, the cumulative DNA damage adds up. Researchers have described excess iron in the presence of oxygen as one of the most common known mutagens. This is why the risk is tied to how much iron builds up in tissues over time, not to a single high-iron meal.
Heme Iron and Colorectal Cancer
The most studied link between dietary iron and cancer involves heme iron, the form found in red and processed meat. Unlike the non-heme iron in plants and supplements, heme iron is absorbed more efficiently and is harder for the body to regulate. It also catalyzes the formation of cancer-promoting compounds directly in the gut lining.
A meta-analysis published in Cancer Prevention Research found that people with the highest heme iron intake had an 18% greater risk of colon cancer compared to those with the lowest intake. That’s a modest but statistically significant increase, and it lines up with the World Health Organization’s classification of processed meat as carcinogenic and red meat as probably carcinogenic. The IARC monograph specifically identifies heme iron as one of several mechanisms that could explain red meat’s cancer link.
This doesn’t mean all red meat consumption is dangerous. The increased risk applies to the highest intake levels compared to the lowest, and it’s one piece of a larger dietary picture. But it does explain why cancer prevention guidelines consistently recommend limiting red and processed meat.
Heme Iron and Breast Cancer
A systematic review of 27 studies found that high heme iron intake was associated with a 12% increase in breast cancer risk. Interestingly, total dietary iron, supplemental iron, and non-heme iron showed no significant association. The link was specific to heme iron from meat and to elevated blood iron levels, which were associated with a 22% higher risk.
This pattern reinforces a consistent theme in the research: the type of iron matters more than the total amount. Heme iron behaves differently in the body than plant-based or supplemental iron, both in how it’s absorbed and in how it interacts with tissues.
Iron Overload and Liver Cancer
The starkest example of iron-driven cancer risk comes from hereditary hemochromatosis, a genetic condition that causes the body to absorb far too much iron from food. People with hemochromatosis accumulate iron in their liver, heart, and pancreas over decades, and the liver bears the heaviest consequences.
A study of men of European ancestry aged 40 to 70 found that those carrying two copies of the most common hemochromatosis gene variant had a 10-fold greater risk of developing liver cancer compared to men without the variant. Life-table projections estimated that 7.2% of men with this genetic makeup will develop liver cancer by age 75, compared to just 0.6% of men without it. That’s a striking difference, and it illustrates what happens when iron accumulates in an organ over a lifetime without intervention.
Hemochromatosis is surprisingly common in people of Northern European descent, affecting roughly 1 in 200 to 300 people. Many don’t know they have it until organ damage has already begun, which is part of why screening with a simple blood test (serum ferritin and transferrin saturation) is recommended for anyone with a family history.
What Ferritin Levels Tell You
Ferritin is the protein your body uses to store iron, and blood ferritin levels serve as a rough gauge of total body iron. Elevated ferritin has been linked to worse outcomes in people who already have cancer, though its role as a predictor of cancer development is less clear-cut.
In cancer patients, high ferritin levels are associated with more aggressive disease. One study of nasopharyngeal cancer patients found that those with ferritin above 164 ng/mL had nearly twice the risk of death and recurrence compared to those with lower levels. Previous research has generally set abnormal ferritin thresholds between 215 and 300 ng/mL, though the optimal cutoff likely varies by context.
For people without cancer, a single ferritin reading doesn’t predict your cancer fate. Ferritin rises with inflammation, infection, and liver disease, so an elevated number needs clinical interpretation. But chronically high ferritin in the absence of these confounders does reflect higher iron stores, which ties back to the oxidative damage mechanism described above.
Do Iron Supplements Raise Risk?
A systematic review of 59 epidemiological studies found no consistent link between total iron intake (food plus supplements) and cancer risk. Results varied across studies: one large U.S. cohort actually found a 25% lower colorectal cancer risk among those with the highest total iron intake, while a Canadian case-control study found a 34% higher risk. The overall picture for supplemental iron is inconclusive and far weaker than the signal for heme iron specifically.
This makes biological sense. Supplemental iron is non-heme iron, which the body regulates more tightly. Your intestinal cells dial absorption up or down based on how much iron you already have. People who are iron-deficient absorb a high percentage of supplemental iron; people with adequate stores absorb very little. This built-in brake doesn’t eliminate risk entirely if someone takes high-dose supplements for years without needing them, but it does explain why supplements don’t show the same pattern as heme iron from meat.
If you’ve been prescribed iron for anemia, the cancer data shouldn’t discourage you from taking it. Iron deficiency itself carries serious health consequences. The concern applies to people who take iron supplements indefinitely without a documented need.
Can Lowering Iron Reduce Cancer Risk?
One of the most provocative findings in this area comes from the FeAST trial, conducted in a Veterans Affairs population of mostly men with peripheral artery disease. Participants were randomized to either periodic blood removal (calibrated to bring ferritin levels down to 25 ng/mL) or standard care. Over 4.5 years, the iron-reduction group had a 35% lower incidence of new cancer diagnoses and a 61% reduction in cancer-specific mortality.
The numbers were striking: 6.0% of the iron-reduction group developed cancer versus 9.3% of the control group. Among those who did develop cancer, the iron-reduction group was about half as likely to die from it. The researchers estimated that for every 30 people treated with periodic blood removal over 4.5 years, one cancer case and one cancer death would be prevented.
These results are compelling but come from a specific population of older men with vascular disease, so they can’t be automatically extended to the general public. Still, they provide some of the strongest direct evidence that lowering iron stores can meaningfully reduce cancer risk. Regular blood donation, which also reduces iron stores, has been suggested as a practical way for healthy people to achieve a similar effect, though this hasn’t been tested in a randomized trial for cancer outcomes specifically.
Iron’s Strange Dual Role in Cancer
In a twist that researchers are actively exploring, the same property that makes iron dangerous to healthy cells can also be turned against cancer. Cancer cells need large amounts of iron to fuel their rapid growth, which makes them vulnerable to a form of cell death called ferroptosis, where iron triggers a chain reaction of fat molecule destruction in cell membranes.
Cancer cells have evolved ways to suppress ferroptosis. Tumor suppressor genes like p53, which are inactivated in most human cancers, normally help promote this iron-dependent death pathway. Melanoma cells preferentially spread through lymph vessels rather than blood specifically to avoid the iron-rich environment that would trigger ferroptosis. And drug-resistant cancer cells depend on protective enzymes that block ferroptosis from occurring.
This has opened a new direction in cancer treatment: deliberately inducing ferroptosis in tumor cells. Early research in animal models shows that disabling cancer cells’ ferroptosis defenses can shrink tumors, reverse drug resistance, and even stimulate the immune system to attack cancer more effectively. The irony is clear: iron helps cause cancer through oxidative damage, but iron-dependent cell death may eventually become a tool for treating it.